The current rules
Since October 2024, Australian doctors cannot write new off-label prescriptions of Ozempic specifically for weight loss. The restriction was introduced because massive off-label demand was creating shortages for type 2 diabetes patients who genuinely needed the medication.
Your GP can still prescribe Ozempic if you have type 2 diabetes — that's its approved use and it's PBS-subsidised at ~$41/script for this purpose.
What about existing patients?
If you were already on off-label Ozempic for weight loss before the restriction, you may be able to continue under your doctor's guidance. The restriction primarily targets new off-label prescriptions. However, the expectation is that existing off-label patients should transition to approved weight loss medications like Wegovy.
Your weight loss alternatives
If you want the same active ingredient (semaglutide) for weight loss:
- Wegovy — semaglutide at 2.4mg (higher than Ozempic's 1mg). TGA-approved for weight loss. $400–460/month but PBS listing is pending.
If you want the most effective option overall:
- Mounjaro — tirzepatide. Different mechanism. ~21% average weight loss vs ~15% for semaglutide. $350–500/month.
If budget is the primary concern:
- Duromine — ~$100/month for 12 weeks. Effective short-term kickstart.
What to say to your GP
If you're interested in weight loss medication, don't ask for Ozempic specifically — ask about "weight loss medication options." Your doctor can then assess which medication is appropriate for your situation and prescribe accordingly. This avoids the awkward conversation about off-label restrictions and opens the door to potentially better options like Wegovy or Mounjaro.